Hypera S.A.
$4.44+0.45%(+$0.02)
TickerSpark Score
70/100
100
Valuation
90
Profitability
25
Growth
76
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYPMY research report →
52-Week Range41% of range
Low $3.71
Current $4.44
High $5.50
Companywww.hyperapharma.com.br
Hypera S. A. operates as a pharmaceutical company in Brazil.
- CEO
- Breno Toledo Pires de Oliveira
- IPO
- 2010
- Employees
- 10,481
- HQ
- São Paulo, SP, BR
Price Chart
-1.55% · this period
Valuation
- Market Cap
- $3.12B
- P/E
- 8.54
- P/S
- 1.85
- P/B
- 1.02
- EV/EBITDA
- 8.14
- Div Yield
- 4.99%
Profitability
- Gross Margin
- 58.96%
- Op Margin
- 28.54%
- Net Margin
- 19.48%
- ROE
- 13.23%
- ROIC
- 9.21%
Growth & Income
- Revenue
- $7.70B · 3.45%
- Net Income
- $1.20B · -10.86%
- EPS
- $1.89 · -10.85%
- Op Income
- $1.74B
- FCF YoY
- 0.44%
Performance & Tape
- 52W High
- $5.50
- 52W Low
- $3.71
- 50D MA
- $4.51
- 200D MA
- $4.44
- Beta
- 0.64
- Avg Volume
- 27.68K
Get TickerSpark's AI analysis on HYPMY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HYPMY Coverage
We haven't published any research on HYPMY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HYPMY Report →Similar Companies
APNHF+0.00%
Aspen Pharmacare Holdings Limited
$8.70
ULIHF+0.00%
The United Laboratories International Holdings Limited
$1.28
HMDCF-23.40%
HUTCHMED (China) Limited
$2.16
VRBCF+0.00%
Virbac S.A.
$408.00
SHWGF+0.00%
Shandong Weigao Group Medical Polymer Company Limited
$0.44
DMPHF+0.00%
Dermapharm Holding SE
$39.56
BVNKF+1.91%
Bavarian Nordic A/S
$30.87
HTSUF+0.00%
Hisamitsu Pharmaceutical Co., Inc.
$29.00